![]() |
市場調査レポート
商品コード
1785177
錠剤コーティング市場- 世界の産業規模、シェア、動向、機会、予測、ポリマー別、用途別、機能別、タイプ別、エンドユーザー別、地域別、市場競争、2020~2030年Tablet Coating Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Polymer, By Application, By Functionality, By Type, By End User, By Region, & Competition, 2020-2030F |
||||||
カスタマイズ可能
|
錠剤コーティング市場- 世界の産業規模、シェア、動向、機会、予測、ポリマー別、用途別、機能別、タイプ別、エンドユーザー別、地域別、市場競争、2020~2030年 |
出版日: 2025年08月06日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
|
錠剤コーティングの世界市場規模は、2024年に9億2,052万米ドルとなり、2030年には12億8,091万米ドルに達すると予測され、CAGRは5.62%です。
世界の錠剤コーティング市場は、経口ドラッグデリバリーシステムの進歩、医薬品・栄養補助食品製造の増加、治療性能と利便性に対する患者の期待の高まりに後押しされた力強い成長を特徴とし、大きな変革期を迎えています。かつては錠剤の外観を向上させ、味をマスキングすることを目的とした二次的なプロセスと見なされていたものが、現在では薬剤の機能性、安定性、標的放出を最適化するための重要なステップとなっています。
市場概要 | |
---|---|
予測期間 | 2026~2030年 |
市場規模:2024年 | 9億2,052万米ドル |
市場規模:2030年 | 12億8,091万米ドル |
CAGR:2025~2030年 | 5.62% |
急成長セグメント | アクリルポリマー |
最大市場 | 北米 |
この市場は、従来型賦形剤のカテゴリーから、製剤イノベーションの戦略的イネーブラーへと移行しつつあり、徐放性製剤、腸溶性製剤、患者に合わせた剤形の開発をサポートしています。世界のヘルスケア動向が慢性疾患管理、セルフメディケーション、個別化治療へと向かう中、機能的性能、規制との整合性、加工効率を実現するコーティングソリューションへの需要は加速し続けています。
医薬品と栄養補助食品の製造活動の成長
厳しい規制状況とコンプライアンス圧力
徐放性と標的ドラッグデリバリーシステムに対する需要の急増
Global Tablet Coating market was valued at USD 920.52 Million in 2024 and is expected to reach USD 1280.91 Million by 2030 with a CAGR of 5.62%. The Global Tablet Coating Market is undergoing a significant transformation, characterized by strong growth fueled by advancements in oral drug delivery systems, increased pharmaceutical and nutraceutical manufacturing, and heightened patient expectations for therapeutic performance and convenience. What was once viewed as a secondary process aimed at enhancing tablet appearance and masking taste has now become a critical step in optimizing drug functionality, stability, and targeted release.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 920.52 Million |
Market Size 2030 | USD 1280.91 Million |
CAGR 2025-2030 | 5.62% |
Fastest Growing Segment | Acrylic Polymer |
Largest Market | North America |
This market is shifting from a traditional excipient category to a strategic enabler of formulation innovation, supporting the development of modified-release, enteric-protected, and patient-tailored dosage forms. As global healthcare trends move toward chronic disease management, self-medication, and personalized therapies, the demand for coating solutions that deliver functional performance, regulatory alignment, and processing efficiency continues to accelerate.
Key Market Drivers
Growing Pharmaceutical and Nutraceutical Manufacturing Activities
As global demand for medications and dietary supplements continues to surge particularly in emerging economies such as India, China, Brazil, and Southeast Asia manufacturers are scaling up production of solid oral dosage forms, especially tablets. China and India collectively account for over 50% of all new drug applications, reflecting the region's rapidly expanding pharmaceutical sector and the growing demand for medications driven by large populations, increasing healthcare access, and rising prevalence of chronic diseases. These high-volume outputs require efficient and high-performance tablet coating systems to ensure product uniformity, protect active pharmaceutical ingredients (APIs), and improve shelf stability. Coatings are no longer just aesthetic; they serve functional roles in ensuring consistent therapeutic performance, especially in climate-sensitive regions. In the pharmaceutical sector, tablet coatings are essential for: Taste masking of bitter APIs, Moisture protection for hygroscopic compounds, Controlled release for improved drug bioavailability, Brand differentiation in a crowded generics market. Similarly, in the nutraceutical space, coatings are used to: Improve visual appeal and consumer acceptance, Enhance swallowability and mask unpleasant tastes or odors, Extend shelf life of active ingredients like probiotics, enzymes, and vitamins.
The proliferation of Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) is also contributing to increased coating demand. These service providers are investing in modern, flexible production facilities equipped with automated, high-throughput coating equipment to meet the growing outsourcing needs of pharmaceutical and nutraceutical brands. As CMOs cater to a wide range of clients each with specific formulation, branding, and compliance requirements they rely heavily on versatile coating systems to deliver tailored solutions across various product categories. This is creating a stable and scalable demand base for coating materials and technologies. As pharmaceutical and nutraceutical manufacturers aim to differentiate their products in increasingly saturated markets, coatings provide a low-cost yet high-impact way to enhance product identity through color, texture, and brand-specific finishes. At the same time, coatings support regulatory compliance by: Meeting Good Manufacturing Practice (GMP) standards, Enabling traceability through ink or logo printing on coated tablets, Enhancing dose accuracy and protection for sensitive ingredients. Nutraceutical companies, in particular, are responding to growing consumer demand for clean-label, vegan, and allergen-free products, which is driving adoption of plant-based, TiO2-free coating solutions. As these manufacturers expand production to meet shifting consumer expectations, the coating market sees parallel growth in demand for specialty formulations.
Key Market Challenges
Stringent Regulatory Landscape and Compliance Pressures
One of the foremost challenges is the increasingly complex regulatory environment governing pharmaceutical coatings. Authorities such as the U.S. FDA, EMA, and other national regulatory bodies are imposing tighter scrutiny on excipients, particularly concerning the safety, biocompatibility, and composition of coating materials. The ongoing push to eliminate substances like titanium dioxide (TiO2) and artificial colorants is forcing manufacturers to reformulate existing products to meet new compliance standards. This process involves substantial R&D investment, stability testing, and validation, which can be time-consuming and costly. For smaller players, regulatory hurdles can slow down product development timelines and act as a barrier to entry, thereby constraining overall market growth.
Key Market Trends
Surge in Demand for Modified-Release and Targeted Drug Delivery Systems
As the pharmaceutical industry increasingly prioritizes patient-centric therapies, there is a growing emphasis on modified-release formulations, including sustained, delayed, and targeted release. Tablet coatings play a critical role in these applications, enabling controlled release profiles, site-specific drug delivery (e.g., enteric coatings for intestinal absorption), and protection of active ingredients from gastric degradation. This demand is especially strong in the treatment of chronic conditions such as cardiovascular diseases, diabetes, and neurological disorders, where consistent drug levels and reduced dosing frequency improve therapeutic outcomes and compliance. As a result, pharmaceutical companies are investing in advanced coating technologies that support next-generation drug delivery systems, propelling growth in this segment.
In this report, the Global Tablet Coating Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Tablet Coating Market.
Global Tablet Coating market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: